An international phase III randomised trial of dose-fractionated chemotherapy compared to standard three-weekly chemotherapy, following immediate primary surgery or as part of delayed primary surgery, for women with newly diagnosed epithelial ovarian, fallopian tube or primary peritoneal cancer
Trial Number
NCT01654146 (ClinicalTrials.gov Identifier)Contact Person
Status
Closed to Recruitment
Disease Site
Ovarian
Lead Cooperative Group
Participating Groups
ANZGOG
GICOM
KGOG
CTI
SAKK